Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California...

Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering...

investors.amgen.com. "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com. Amgen - Investors - Press Release Amgen - Investors...

underreporting in the FOURIER study have attracted some controversy in the media. Amgen submitted a biologics license application (BLA) for evolocumab to the FDA...

The Centre for Alternative Technology (CAT) (Welsh: Canolfan y Dechnoleg Amgen) is an eco-centre in Montgomeryshire, Powys, Wales dedicated to demonstrating...

American businessman. He is the chairman and chief executive officer of Amgen. Bradway holds a B.S. degree in biology from Amherst College and an MBA...

Blinatumomab In Acute Lymphoblastic Leukemia" (Press release). Amgen. 1 July 2014. "Amgen's BiTE Immunotherapy Blinatumomab Receives FDA Priority Review...

The Tour of California (officially sponsored as the Amgen Tour of California) was an annual professional road cycling stage race on the UCI World Tour...

Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd. is a decision by the House of Lords of England and Wales. The judgment was issued on 21 October 2004 and...

Irish Open (Irish: Comórtas Oscailte na hÉireann), currently titled as the Amgen Irish Open for sponsorship reasons, is a professional golf tournament on...

The 2008 Tour of California was the third edition of an eight-day, 650-mile (1,045 km) stage race, which began in Palo Alto (Stanford University), then...

United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023. In 2014, Horizon executed a tax inversion...

trial. Obicetrapib was initially developed by Amgen as AMG-899 and was abandoned in 2017. In 2020, Amgen licensed the drug to NewAmsterdam Pharma. Ballantyne...

the UK in 2015. In 2019, Amgen acquired Otezla from Celgene for $13.4 billion. In 2020, Otezla generated $2.2 billion for Amgen. Apremilast was listed on...

The 2016 Amgen Tour of California Women's Race (also known as the Amgen Breakaway From Heart Disease Women's Race Empowered by SRAM for sponsorship reasons)...

cells that break down bone. It was developed by the biotechnology company Amgen. Denosumab is used for those with osteoporosis at high risk for fractures...

The 2015 Amgen Tour of California was the tenth edition of the Tour of California cycling stage race. It was held from May 10–17, and rated as a 2.HC...

The Amgen Helix Pedestrian Bridge is a pedestrian bridge in Seattle, in the U.S. state of Washington. The bridge was designed by Johnson Architecture...

chronic kidney failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp. The medication was approved in September 2001...

received at least one prior systemic therapy. Sotorasib is being developed by Amgen. Phase I clinical trials were completed in 2020. In December 2019, it was...

eventually sold the license to News Corp. In 2006, Salzman co-founded the AMGEN Tour of California. The Tour of California is the only event on the top-level...

in humans). Panitumumab is manufactured by Amgen and was originally developed by Abgenix Inc. In 2014, Amgen and Illumina entered into an agreement to...

right treatment pathway for breast cancer patients. Owkin collaborated with Amgen to test the ability of AI to improve cardiovascular prediction. In November...

June 2013, Cytokinetics and Amgen expanded their licensing deal for omecamtiv mecarbil to include Japan. In November 2020 Amgen elected to terminate the...

calcium-sensing receptor in the parathyroid gland. Parsabiv is currently owned by Amgen and Ono Pharmaceuticals in Japan. Etelcalcetide is used for the treatment...

its headquarters to the Interbay neighborhood of Seattle, purchasing the Amgen campus on the Elliott Bay waterfront for $228.9 million and investing an...

entered into two collaboration and licensing agreements with Amgen. Under the deals, Amgen received a worldwide exclusive license to Arrowhead’s ARO-LPA...

needed] and the Amgen Bioprocessing Center. The Amgen Bioprocessing Center was funded by a 2004 grant of $2 million to KGI from Amgen, a pharmaceutical...

with chronic immune thrombocytopenic purpura. Romiplostim was developed by Amgen through a restricted usage program called NEXUS. During development and...

Full caption: Amgen Inc., et al. v. Steve Harris, et al. Citations: 577 U.S. ___ Prior history: Dismissed, No. 07-05442, C.D. Cal.; rev'd, 738 F. 3d 1026...